<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Phillips EA</submitter><funding>National Institute of Allergy and Infectious Diseases</funding><funding>Bill &amp; Melinda Gates Foundation - Grand Challenges Explorations Initiative</funding><funding>NIAID NIH HHS</funding><funding>Purdue University</funding><funding>Bill and Melinda Gates Foundation</funding><funding>Division of Graduate Education</funding><pagination>3375-3386</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC7384476</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(20)</volume><pubmed_abstract>While identifying acute HIV infection is critical to providing prompt treatment to HIV-positive individuals and preventing transmission, existing laboratory-based testing methods are too complex to perform at the point of care. Specifically, molecular techniques can detect HIV RNA within 8-10 days of transmission but require laboratory infrastructure for cold-chain reagent storage and extensive sample preparation performed by trained personnel. Here, we demonstrate our point-of-care microfluidic rapid and autonomous analysis device (microRAAD) that automatically detects HIV RNA from whole blood. Inside microRAAD, we incorporate vitrified amplification reagents, thermally-actuated valves for fluidic control, and a temperature control circuit for low-power heating. Reverse transcription loop</pubmed_abstract><journal>Lab on a chip</journal><pubmed_title>Microfluidic rapid and autonomous analytical device (microRAAD) to detect HIV from whole blood samples.</pubmed_title><pmcid>PMC7384476</pmcid><funding_grant_id>R61AI140474</funding_grant_id><funding_grant_id>R61 AI140474</funding_grant_id><funding_grant_id>DGE-1333468</funding_grant_id><funding_grant_id>OPP1150806</funding_grant_id><pubmed_authors>Jankowski LA</pubmed_authors><pubmed_authors>Lin LK</pubmed_authors><pubmed_authors>Ejendal KFK</pubmed_authors><pubmed_authors>Byers KM</pubmed_authors><pubmed_authors>Hoilett OS</pubmed_authors><pubmed_authors>Bennett JB</pubmed_authors><pubmed_authors>Phillips EA</pubmed_authors><pubmed_authors>Basing LA</pubmed_authors><pubmed_authors>Stanciu LA</pubmed_authors><pubmed_authors>Moehling TJ</pubmed_authors><pubmed_authors>Linnes JC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Microfluidic rapid and autonomous analytical device (microRAAD) to detect HIV from whole blood samples.</name><description>While identifying acute HIV infection is critical to providing prompt treatment to HIV-positive individuals and preventing transmission, existing laboratory-based testing methods are too complex to perform at the point of care. Specifically, molecular techniques can detect HIV RNA within 8-10 days of transmission but require laboratory infrastructure for cold-chain reagent storage and extensive sample preparation performed by trained personnel. Here, we demonstrate our point-of-care microfluidic rapid and autonomous analysis device (microRAAD) that automatically detects HIV RNA from whole blood. Inside microRAAD, we incorporate vitrified amplification reagents, thermally-actuated valves for fluidic control, and a temperature control circuit for low-power heating. Reverse transcription loop</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Oct</publication><modification>2025-04-19T23:05:12.278Z</modification><creation>2025-04-19T23:05:12.278Z</creation></dates><accession>S-EPMC7384476</accession><cross_references><pubmed>31539001</pubmed><doi>10.1039/c9lc00506d</doi></cross_references></HashMap>